Serum Institute gets nod to conduct Novavax COVID vaccine’s bridging trials in India
New Delhi: The Subject Expert Committee of India's central drug regulatory authority has given a go-ahead to the Serum Institute of India to conduct Phase 2 and 3 clinical trials for Novavax's Covid vaccine candidate in the country.…